Jaber 1996.

Methods	RCT (randomised by patient) Randomisation concealment: NOT CLEAR Follow up: ‐ providers: N/A ‐ patients: DONE Blinded assessment: DONE for laboratory outcomes, health related quality of life NOT CLEAR for blood pressure, weight, patient compliance Baseline: DONE for fasting plasma glucose, glycated haemoglobin, serum Creatinine, BMI microalbumin/Creatinine ratio, total body weight NOT CLEAR for the other outcomes Reliable outcomes: DONE for laboratory outcomes, health related quality of life NOT CLEAR for blood pressure, weight, patient compliance Protection against contamination: NOT CLEAR
Participants	A university‐affiliated general internal medicine outpatient clinic (US). Intervention group received care by a pharmacist, the control group by physicians. Urban African‐American patients attending the clinic. Of 156 eligible patients 45 were randomised and 39 completed the study (Type 2 diabetes). providers ‐ ? (pharmacist + physicians) patients ‐ 45 practices ‐ 1 outpatient clinic
Interventions	Intervention group: Organisational intervention (revision of professional roles (all diabetes‐related management aspects were solely provided by a pharmacist) + patient education on glycaemic control and self‐monitoring of blood glucose Control group: usual care by physician Length of intervention: 4 months
Outcomes	PROCESS: NONE PATIENT: Primary outcomes: Fasting plasma glucose Glycated haemoglobin Secondary outcomes: Blood pressure Body weight Serum lipid measurements Renal function parameters Quality of life
Notes	Care was provided consistent with, but broader than that described by Helper and Strand (reference 16 in study). The guidelines are not specified. ‐directed at treatment ‐targets: glycaemic control secondary targets: blood pressure, body weight serum lipid measurements, renal function parameters, quality of life
Risk of bias
Bias	Authors' judgement	Support for judgement
Allocation concealment?	Unclear risk	B ‐ Unclear